Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Pediatrics & Neonatal Biology Open Access Research Article 4 min read

Probiotics: How Do We Know

Miljana Z Jovandaric*
* Corresponding author
ISSN: 2640-2726  10.23880/pnboa-16000101  Received: June 29, 2016  Published: July 04, 2016
  views
 10 references
PDF
Keywords
Probiotics Health Safety
Abstract

Probiotics are live bacteria and yeasts that are good for your health, especially your digestive system. We usually think of bacteria as something that causes diseases. But your body is full of bacteria, both good and bad. Probiotics are often called "good" or "helpful" bacteria because they help keep your gut healthy. Probiotics are naturally found in your body. You can also find them in some foods and supplements.

Introduction

Many types of bacteria are classified as probiotics. They all have different benefits, but most come from two groups [1]. a) Lactobacillus: This may be the most common probiotic. It’s the one you’ll find in yogurt and other fermented foods. Different strains can help with diarrhea and may help with people who can’t digest lactose, the sugar in milk [2]. b) Bifidobacterium: You can also find it in some dairy products. It may help ease the symptoms of irritable bowel syndrome [3, 4].

Probiotics have received renewed attention recently from product manufacturers, research studies, and consumers [5]. The fermentation of dairy foods represents one of the oldest techniques for food preservation [6]. According to Metchnikoff, these compounds were responsible for what he called "intestinal autointoxication", which would cause the physical changes associated with old age [7, 8].

Opinion

Probiotics are under considerable research, as the concept holds promise for human health and well- being, and corresponding commercial opportunities. Protection of consumers requires health claims to be confirmed with sufficient scientific evidence. Overall scientific demonstration of probiotic effects requires defining a healthy microbiota and interactions between microbiota and host, and the difficulty to characterize probiotic effectiveness in health and disease. Recent developments of high-throughput sequencing technology and the consequent progresses of metagenomics represent a new approach for the future of probiotics research [9].

There’s preliminary evidence that some probiotics are helpful in preventing diarrhea caused by infections and antibiotics and in improving symptoms of irritable bowel syndrome, but more needs to be learned. We still don’t know which probiotics are helpful and which are not. We also don’t know how much of the probiotic people would have to take or who would most likely benefit from taking probiotics. Even for the conditions that have been studied the most, researchers are still working toward finding the answers to these questions [1].

Probiotics are not all alike. For example, if a specific kind of Lactobacillus helps prevent an illness, that doesn’t necessarily mean that another kind of Lactobacillus would have the same effect or that any of the Bifidobacterium probiotics would do the same thing [4].

Even for healthy people, there are uncertainties about the safety of probiotics. Because many research studies on probiotics haven’t looked closely at safety, there isn’t enough information right now to answer some safety questions. Most of our knowledge about safety comes from studies of Lactobacillus and Bifidobacterium; less is known about other probiotics. Information on the long-term safety of probiotics is limited, and safety may differ from one type of probiotic to another. For example, even though a National Center for Complementary and Integrative Health (NCCIH)-funded study showed that a particular kind of Lactobacillus appears safe in healthy adults age 65 and older, this does not mean that all probiotics would necessarily be safe for people in this age group [10].

Conclusion

Probiotics are under considerable research, as the concept holds promise for human health and well- being, and corresponding commercial opportunities. Protection of consumers requires health claims to be confirmed with sufficient scientific evidence. Overall scientific demonstration of probiotic effects requires defining a healthy microbiota and interactions between microbiota and host, and the difficulty to characterize probiotic effectiveness in health and disease.

References

  1. Rolfe RD (2000) The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130(2S): 396S-3402S.
  2. Hatakka K, Savilahti E, Pönkä A, Meurman JH, Poussa T, et al. (2001) Effect of longterm consumption of probiotic milk on infection in children attending daycare centers; double blind randomised trial. BMJ 332: 1-5.
  3. Anderson (1999) Effect of fermented milk (yogurt) containing Lactobacillus acidophilis L1 on serum cholesterol in hyper cholesterolemia in humans. J Am College of Nutr 18(1): 43-50.
  4. Hove H, Nørgaard H, Mortensen PB (1999) Lactic acid bacteria and the human gastrointestinal tract. Eur J Clin Nutr 53(5): 339-350.
  5. Gismondo MR, Drago L, Lombardi A (1999) Review of probiotics available to modify gastrointestinal flora. Int J Antimicrob Agents 12(4): 287-292.
  6. Cerbo ADi, Palmieri B (2015) Review: The market of probiotics. Pak J Pharm Sci 28(6): 2199-2206.
  7. Caramia G (2004) [Probiotics: from Metchnikoff to the current preventive and therapeutic possibilities]. Pediatr Med Chir 26(1): 19-33.
  8. Bested AC, Logan AC, Selhub EM (2013) Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part I - autointoxication revisited. Gut Pathog 5(1): 5.
  9. Gueimonde M, Collado MC (2012) Metagenomics and probiotics Clin Microbiol Infect. 18 Suppl 4: 32-4.
  10. Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach J et al. (2010) Safety assessment of probiotics for human use. Gut Microbes 1(3): 64-85.

Cite this article

BibTeX
APA
RIS
@article{miljana2016,
  title   = {Probiotics: How Do We Know},
  author  = {Miljana Z Jovandaric},
  journal = {Pediatrics & Neonatal Biology Open Access},
  year    = {2016},
  volume  = {1},
  number  = {1},
  doi     = {10.23880/pnboa-16000101}
}
Miljana Z Jovandaric (2016). Probiotics: How Do We Know. Pediatrics & Neonatal Biology Open Access, 1(1). https://doi.org/10.23880/pnboa-16000101
TY  - JOUR
TI  - Probiotics: How Do We Know
AU  - Miljana Z Jovandaric
JO  - Pediatrics & Neonatal Biology Open Access
PY  - 2016
VL  - 1
IS  - 1
DO  - 10.23880/pnboa-16000101
ER  -